The responses of 1,948 women aged 40 to 49 were detailed recently in Academic Radiology, where researchers offered detailed insight into what factors influence women at average risk of breast cancer to seek or delay screening at certain ages. 

Although there are no current government regulations pertaining to the amount of CT scans individuals can have in a year, new survey data suggest many practicing clinicians support the notion. 

Payam Toobian, MD, is alleged to have paid kickbacks in the form of gift cards, checks and cash to physicians in exchange for referrals to his Queens imaging center—Empire Imaging—from January 2006 to August 2017.

The findings are the result of an analysis of more than 13,000 imaging reports containing additional follow-up recommendations.

Women who skipped screening due to financial concerns outnumbered those who were not screened due to logistical issues such as scheduling and transportation conflicts, new survey data reveals. 

Bracco Diagnostics, Inc has been given the go ahead by the U.S. Food and Drug Administration to temporarily import Iomeron (iomeprol injection) into the U.S. market amid the ongoing iodinated contrast media shortage. 

On July 18 Fresenius Kabi announced that they are rolling out a line of generic contrast media products, starting immediately with Iodixanol Injection USP. 

Per Bayer’s communications, the contrast agent is manufactured at the same site in Berlin, Germany as the Ultravist that is intended for U.S. markets, but due to its intended distribution abroad it lacks current FDA-approved labeling.